Joaquin Duato
Chairman/CEO
Johnson & Johnson · JNJ
$32.8M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 11, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.6M
- Stock Awards
- $15M
- Option Awards
- $5.9M
- Incentives
- $4.3M
- Other
- $5.9M
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,600,000 | $15,028,948 | $32,758,111 |
| 2024 | $1,600,000 | $10,787,159 | $24,302,360 |
| 2023 | $1,584,615 | $11,182,143 | $28,397,240 |
Current Position
- Company
- Johnson & Johnson
- Title
- Chairman/CEO
- Ticker
- JNJ · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 11, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0000200406-26-000063.
Other Johnson & Johnson Executives
Joseph Wolk
EVP, CFO
Johnson & Johnson · JNJ
$14.4M
FY 2025 · DEF 14A
J. Taubert
EVP, WWC Innovative Medicine
Johnson & Johnson · JNJ
$14M
FY 2025 · DEF 14A
J. Reed
EVP, Innovative Medicine, R&D
Johnson & Johnson · JNJ
$12.2M
FY 2025 · DEF 14A
T. Schmid
EVP, WWC, Med Tech
Johnson & Johnson · JNJ
$9.3M
FY 2025 · DEF 14A